Draegerwerk AG & Co. KGaA · XETR:DRW8

Draegerwerk AG & Co. KGaA — Drägerwerk AG & Co. KGaA — 9M 2015 Earnings Presentation

18 slides from Draegerwerk AG & Co. KGaA's earnings presentation, Nov 5, 2015

  1. Slide 1: Conference call Interim report January 1 to September 30, 2015

    Conference call Interim report January 1 to September 30, 2015 Lübeck, November 5, 2015

  2. Slide 2: Disclaimer

    Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d

  3. Slide 3: Business development Group

    Business development Group Net Sales Order entry Q3 +3.5% (cc +1.2%) +0.2% +2.3% 9M +8.7% (cc +3.8%) Currency Currency 1,783.6 Book to bill 1.06 (py 1.05) adjusted adjusted 9M Net sales Net of 604.0 Change currency 1,664.9 in € million in % effects in % 591.8 Europe +6.6 +6.0 Americas +8.4 - 2.9 Asi

  4. Slide 4: Functional Expenses

    Functional Expenses Change 9M 2014 9M 2015 Change FX adj. Mio. € Mio. € % % R&D -155.4 -174.9 12.6 6.5 % of Net Sales -9.3% -9.8% Sales & Marketing -399.6 -445.6 11.5 6.0 % of Net Sales -24.0% -25.0% Administration -142.9 -164.8 15.3 11.5 % of Net Sales -8.6% -9.2% SG&A -542.5 -610.4 12.5 7.4 % of N

  5. Slide 5: Medical division: order entry in Q3 2015 and 9M 2015

    Business development Medical division: order entry in Q3 2015 and 9M 2015 % nom % cc % nom % cc 420.6 +1.8% -0.9% 1235.0 +9.0% +3.8% Middle East, 39.9 -24.7% -29.9% +12.7% +4.5% 134.6 Africa & Others +20.6% +13.6% +16.9% +5.0% 82.3 225.4 Asia/Pacific +12.3% +7.0% +14.4% +3.9% 89.7 254.8 Americas -1.

  6. Slide 6: Medical division

    Business development Medical division Net Sales Order entry +0.2% +2.6% Q3 +1.8% (cc -0.9%) Currency Currency 9M +9.0% (cc +3.8%) adjusted adjusted 1,148.2 Book to bill 1.08 (py 1.07) 1,063.1 9M Net sales Net of 378.8 388.1 Change currency in € million in % effects in % Europe +7.2 +6.8 Q3‘14 Q3‘15

  7. Slide 7: Safety division: order entry in Q3 2015 and 9M 2015

    Business development Safety division: order entry in Q3 2015 and 9M 2015 % nom % cc % nom % cc 225.2 660.0 +8.1% +3.8% Middle East, +6.9% +5.2% Africa & Others 15.9 +10.9% +9.5% 42.0 +10.7% +5.2% +9.1% +6.5% 102.8 +12.2% +3.0% 35.0 Asia/Pacific +8.7% +1.4% +10.3% -2.0% 38.9 112.9 Americas +5.3% +5.4

  8. Slide 8: Safety division

    Business development Safety division Net Sales Order entry Q3 +6,9% (cc +5.2%) +0.0% +1.6% 9M +8.1% (cc +3.8%) Currency Currency 635.3 Book to bill 1.04 (py 1.01) adjusted 601.8 adjusted 9M Net sales Net of Change currency 213.0 216.0 in € million in % effects in % Europe +5.7 +5.0 Q3‘14 Q3‘15 9M'14

  9. Slide 9: Key Figures

    Key Figures 9M 2014 9M 2015 Change Mio. € Mio. € % Cashflow from operating activities 71.0 -7.2 -110.1 Investments 84.1 156.7 86.3 1 Cash and cash equivalents 175.4 128.7 -26.6 1 Net financial debt 118.9 165.5 39.1 1 2 0.5 0.9 Net financial debt /EBITDA 1 Capital employed 1,112.9 1,256.4 12.9 2 1 15

  10. Slide 10: Outlook

    Outlook 2014 2015e Net Sales + 4.0% 1.0% – 3.0% (net of currency effects) (net of currency effects) EBIT margin 7.3% 2.5% – 4.5%* Gross margin 46.7% below prior year Operating 105.0% > 50.0% cash flow of EBIT of EBIT Equity ratio 40.1% > 40.0% * Based on exchange rates at the end of Q3; excluding po

  11. Slide 11: Questions & Answers

    Questions & Answers Drager ee “e 1 Drager. Technik fiir das Leben®

  12. Slide 12: Appendix

    Appendix Drager 12

  13. Slide 13: Dräger Group

    Business development Dräger Group Q3 2014 Q3 2015 Change 9M 2014 9M 2015 Change € million € million % € million € million % Order Intake 624.0 645.7 3.5 1 1,743.4 1,895.1 8.7 1 Net Sales 591.8 604.0 2.1 1 1,664.9 1,783.6 7.1 1 % growth 6.6% 2.1% 0.5% 7.1% % growth (currency adjusted) 6.7% 0.2% 3.0%

  14. Slide 14: Medical and Safety division

    Business development Medical and Safety division Medical Division Q3 2014 Q3 2015 Change 9M 2014 9M 2015 Change Mio. € Mio. € % Mio. € Mio. € % Order Intake 413.3 420.6 1.8 1 1,132.7 1,235.0 9.0 1 Net Sales 378.8 388.1 2.5 1 1,063.1 1,148.2 8.0 1 EBIT 26.2 -24.1 -191.7 35.8 -9.1 -125.4 EBIT Margin 6

  15. Slide 15: Functional Expenses

    Functional Expenses Q3 2014 Q3 2015 Change 9M 2014 9M 2015 Change Mio. € Mio. € % Mio. € Mio. € % R&D -51.8 -60.1 16.0 -155.4 -174.9 12.6 % of Net Sales -8.8% -9.9% -9.3% -9.8% Sales & Marketing -136.8 -152.5 11.5 -399.6 -445.6 11.5 % of Net Sales -23.1% -25.2% -24.0% -25.0% Administration -52.9 -57

  16. Slide 16: Cash-flow statement

    Cash-flow statement 9M 2014 9M 2015 Change Mio. € Mio. € % Group net profit 42.5 -11.1 >-100 Change in inventories -50.8 -76.4 -50.4 Change in accounts receivables 81.7 71.3 -12.8 Change in accounts payables -23.1 -25.0 -8.0 Depreciation and amortization 54.5 61.9 13.6 Other operating cash flow item

  17. Slide 17: Financial calendar

    Financial calendar March 11, 2015 - Accounts press conference, Lübeck - Analysts meeting, Frankfurt April 29, 2015 - Report for the first three months 2015 - Conference call, Lübeck April 30, 2015 - Annual shareholders' meeting, Lübeck July 30, 2015 - Report for the first six months 2015 - Conferenc

  18. Slide 18: Contact

    Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88

Drägerwerk AG & Co. KGaA — 9M 2015 Earnings Presentation on 6ix